| [1] |
Ferlay J, Soerjomataram I, Dikshit R, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer,2015,136:E359-386.
|
| [2] |
Endig J, Buitrago-Molina LE, Marhenke S, et al.Dual role of the adaptive immune system in liver injury and hepatocellular carcinoma development. Cancer Cell, 2016,30:308-323.
|
| [3] |
Gun SY, Lee SWL, Sieow JL, et al.Targeting immune cells for cancer therapy. Redox Biol, 2019,101-174.
|
| [4] |
Okusaka T, Ikeda M.Immunotherapy for hepatocellular carcinoma: current status and future perspectives. ESMO Open, 2018,3:e000455
|
| [5] |
Scott CL, Zheng F, De Baetselier P, et al.Bone marrow-derived monocytes give rise to self-renewing and fully diferentiated Kupfer cells. Nat Commun, 2016,7:10321.
|
| [6] |
Yu LX, Ling Y, Wang HY.Role of nonresolving infammation in hepatocellular carcinoma development and progression. NPJ Precis Oncol,2018,2:6.
|
| [7] |
Liang S, Ma HY, Zhong Z, et al.NADPH oxidase 1 in liver macrophages promotes infammation and tumor development in mice. Gastroenterology, 2018,156:1156-1172.
|
| [8] |
Galdiero MR, Bonavita E, Barajon I, et al.Tumor associated macrophages and neutrophils in cancer. Immunobiology, 2013,218:1402-1410.
|
| [9] |
Yang Y, Ye YC, Chen Y, et al.Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Cell Death Dis,2018,9:793.
|
| [10] |
Dong P, Ma L, Liu L, et al.CD86(+)/CD206(+), diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis. Int J Mol Sci, 2016,17:320.
|
| [11] |
Liu JY, Chiang T, Liu CH, et al.Delivery of siRNA using CXCR4-targeted nanoparticles modulates tumor microenvironment and achieves a potent antitumor response in liver cancer, Mol Ther, 2015,23:1772-1782.
|
| [12] |
Zang M, Li Y, He H, et al.IL-23 production of liver infammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection. Biochim Biophys Acta Mol Basis Dis, 2018,1864:3759-3770.
|
| [13] |
Zhang YL, Li Q, Yang XM, et al.SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis by distinct integrin-Rho GTPase-Hippo pathways. Can Res, 2018,78:2305-2317.
|
| [14] |
Yao RR, Li JH, Zhang R, et al.M2-polarized tumorassociated macrophages facilitated migration and epithelial-mesen chymal transition of HCC cells via the TLR4/STAT3 signaling pathway. World J Surg Oncol, 2018,16:9.
|
| [15] |
Wan S, Zhao E, Kryczek I, et al.Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology,2014,147:1393-1404.
|
| [16] |
Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, et al.Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett, 2014,352:160-168.
|
| [17] |
Yao W, Ba Q, Li X, Li H, Zhang S, Yuan Y, et al.A natural CCR93 antagonist relieves tumor-associated macrophage-mediated immunosuppression to produce a therapeutic efect for liver cancer. EBioMedicine, 2017,22:58-67.
|
| [18] |
Wu J, Li J, Salcedo R, Mivechi NF, Trinchieri G, Horuzsko A.The proinfammatory myeloid cell receptor TREM-1 controls Kupfer cell activation and development of hepatocellular carcinoma. Can Res, 2012,72:3977-86.
|
| [19] |
Li X, Yao W, Yuan Y, Chen P, Li B, Li J, et al.Targeting of tumourinfltrating macrophages via CCL2/CCR103 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut, 2017,66:157-67.
|
| [20] |
Tan HY, Wang N, Man K, Tsao SW, Che CM, Feng Y.Autophagyinduced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin. Cell Death Dis, 2015,6:e1942.
|
